These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35961555)

  • 1. Untargeted metabolomics reveals the role of AQP9 in nonalcoholic fatty liver disease in a mice model.
    Cheng Q; Zhang J; Fang J; Ding H; Xu Y; Lu X; Zhang W
    Int J Biol Macromol; 2022 Oct; 219():864-875. PubMed ID: 35961555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untargeted metabonomics reveals intervention effects of chicory polysaccharide in a rat model of non-alcoholic fatty liver disease.
    Zhu H; Wang Z; Wu Y; Jiang H; Zhou F; Xie X; Wang R; Hua C
    Int J Biol Macromol; 2019 May; 128():363-375. PubMed ID: 30690116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of pharmacodynamics and metabolomics to reveal rhubarb anthraquinone protection against nonalcoholic fatty liver disease rat model.
    Zhang F; Wu R; Liu Y; Dai S; Gong X; Li Y
    J Pharm Pharmacol; 2024 Apr; 76(4):381-390. PubMed ID: 38349666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver Metabolomics Analysis Revealing Key Metabolites Associated with Different Stages of Nonalcoholic Fatty Liver Disease in Hamsters.
    Gao SS; Shen YL; Chen YW; Wei XZ; Hu JJ; Wang J; Wu WJ
    Comb Chem High Throughput Screen; 2024; 27(9):1303-1317. PubMed ID: 37859316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic-proteomic combination analysis reveals the targets and molecular pathways associated with hydrogen sulfide alleviating NAFLD.
    Liu Z; Liu M; Fan M; Pan S; Li S; Chen M; Wang H
    Life Sci; 2021 Jan; 264():118629. PubMed ID: 33131747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics Characterizes the Effects and Mechanisms of Quercetin in Nonalcoholic Fatty Liver Disease Development.
    Xu Y; Han J; Dong J; Fan X; Cai Y; Li J; Wang T; Zhou J; Shang J
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatoprotective Effects of
    Jin W; Cho S; Laxi N; Bao T; Dai L; Yu H; Qi R; Zhang J; Ba G; Fu M
    Molecules; 2022 May; 27(10):. PubMed ID: 35630624
    [No Abstract]   [Full Text] [Related]  

  • 9. A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease.
    Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Kim DJ; Suk KT
    Life Sci; 2023 Jun; 322():121626. PubMed ID: 37003543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics analysis of the serum metabolic signature of nonalcoholic fatty liver disease combined with prediabetes model rats after the intervention of Lycium barbarum polysaccharides combined with aerobic activity.
    Fan Y; Zhang M; Ma J; Zhang Y; Yang J
    Biomed Chromatogr; 2023 Apr; 37(4):e5562. PubMed ID: 36480472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum untargeted metabolomics analysis of the preventive mechanism of TAETEA Prebiotea on non-alcoholic fatty liver in rats.
    Zhang S; Li J; Zhai Y; Xu J; Wang Y; Ding X; Qiu X
    J Pharm Biomed Anal; 2024 Sep; 247():116218. PubMed ID: 38810332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of hepatic aquaglyceroporin-9 alleviates high fat diet-induced non-alcoholic fatty liver disease in rats.
    Cai C; Wang C; Ji W; Liu B; Kang Y; Hu Z; Jiang Z
    Int Immunopharmacol; 2013 Mar; 15(3):550-6. PubMed ID: 23415870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated multiomics analysis reveals changes in liver physiological function in Aqp9 gene knockout mice.
    Cheng Q; Zhang J; Ding H; Wang Z; Fang J; Fang X; Li M; Li R; Meng J; Liu H; Lu X; Xu Y; Chen C; Zhang W
    Int J Biol Macromol; 2023 Aug; 245():125459. PubMed ID: 37353119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS.
    Yan X; Li L; Liu P; Xu J; Wang Z; Ding L; Yang L
    J Pharm Biomed Anal; 2022 Mar; 211():114620. PubMed ID: 35124446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction of short hairpin RNA targeting aquaglyceroporin 9 and screening its effect on molecular mechanisms of nonalcoholic fatty liver disease using a cell model system].
    Wang C; Kang YJ; Jiang Z; Wang PL
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):222-7. PubMed ID: 23967746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice.
    Chao J; Huo TI; Cheng HY; Tsai JC; Liao JW; Lee MS; Qin XM; Hsieh MT; Pao LH; Peng WH
    PLoS One; 2014; 9(2):e96969. PubMed ID: 24918580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Untargeted metabonomic analysis of non-alcoholic fatty liver disease with iron overload in rats via UPLC/MS.
    Shen Y; Li X; Xiong S; Hou S; Zhang L; Wang L; Dai X; Zhao Y
    Free Radic Res; 2023 Dec; 57(3):195-207. PubMed ID: 37326040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes.
    Liu XL; Ming YN; Zhang JY; Chen XY; Zeng MD; Mao YM
    Exp Mol Med; 2017 Jan; 49(1):e283. PubMed ID: 28082742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial metabolomic profiling for elucidating the alleviating potential of
    Yang XX; Wei JD; Mu JK; Liu X; Li FJ; Li YQ; Gu W; Li JP; Yu J
    World J Gastroenterol; 2019 Nov; 25(43):6404-6415. PubMed ID: 31798277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Hesperidin Supplementation on Liver Metabolomics and Gut Microbiota in a High-Fat Diet-Induced NAFLD Mice Model.
    Li X; Yao Y; Wang Y; Hua L; Wu M; Chen F; Deng ZY; Luo T
    J Agric Food Chem; 2022 Sep; 70(36):11224-11235. PubMed ID: 36048007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.